Focus Partners Wealth
GSK icon

Focus Partners Wealth’s GSK GSK Stock Holding History

Focus Partners Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.32M Buy
96,270
+29,344
+44% +$1.59M 0.01% 919
2025
Q4 		$3.29M Buy
66,926
+18,127
+37% +$845K ﹤0.01% 1119
2025
Q3 		$2.07M Buy
48,799
+8,776
+22% +$343K ﹤0.01% 1002
2025
Q2 		$1.54M Buy
40,023
+357
+0.9% +$13.6K ﹤0.01% 984
2025
Q1 		$1.54M Sell
39,666
-4,588
-10% -$168K ﹤0.01% 922
2024
Q4 		$1.5M Buy
44,254
+9,235
+26% +$332K ﹤0.01% 932
2024
Q3 		$1.43M Buy
35,019
+22,359
+177% +$915K ﹤0.01% 856
2024
Q2 		$487K Buy
+12,660
New +$533K ﹤0.01% 957

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Focus Partners Wealth's GSK Position: Q1 2026 in Review

Focus Partners Wealth increased its GSK (GSK) stake by 44% in Q1 2026, buying an estimated $1.59M and bringing the position to 96,270 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #919.

Focus Partners Wealth first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Focus Partners Wealth held 96,270 shares of GSK worth $5.32M as of Q1 2026.
  • Focus Partners Wealth bought 29,344 GSK shares in Q1 2026, an estimated $1.59M.
  • GSK made up 0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #919 holding.
  • Focus Partners Wealth first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.